Review of Management, Maternal and Fetal Outcomes in Women with Eclampsia in Kogi Eastern Hospitals, North Central Nigeria

Authors

  • Simon Peterside Onuche Akogu Obstetrics and gynecology Department, Kogi State University/Kogi State University Teaching Hospital, Anyigba
  • Musa Abdulkarim Omoniyi Department of Obstetrics and Gynaecology, Federal Teaching Hospital, Lokoja Kogi State
  • Christian Ekpe Department of Physiology/Obstetrics and Gynecology, Prince Abubakar Audu University/prince Abubakar Audu University Teaching Hospital Anyigba
  • Timothy Idachaba Nursing Services Division, Prince Abubakar Audu University Teaching Hospital, Anyigba
  • Funmilola Alakpo Nursing Services Division, Prince Abubakar Audu University Teaching Hospital, Anyigba

DOI:

https://doi.org/10.14738/bjhmr.115.17521

Keywords:

Eclampsia, maternal outcomes, fetal outcomes, obstetric management, pregnancy complications

Abstract

Introduction: Eclampsia is defined as the occurrence of convulsion with the syndrome of preeclampsia. Pre-eclampsia is a multi-systemic disease typified by raised blood pressure and proteinuria [1, 2, 3, 20]. This study reviewed Eclampsia management protocols including patients care instructions, oxygen administration, use of antihypertensive, anticonvulsant, maternal outcome and neonatal outcome. This type of enquiry will generate information that will stimulate systems wide appraisals for improvement in the management of Eclampsia. Material and Methods: This is a retrospective case series study. Case files of consecutive cases of eclampsia managed between January 2018 and December 2022 in the 5 hospitals in Kogi East, North central Nigeria were extracted. Using a structured questionnaire, information on bio data, relevant obstetrics characteristics, case management and outcome were obtained and analyzed. Results: Majority of parturient are in the age range of 20 – 34 years (43.7%). There were 3321 deliveries. 135 of the women had eclampsia while 11 women died from complications of eclampsia. The maternal mortality ratio due to eclampsia is 332 per 100,000 live births. The case fatality rate for eclampsia in this study is 8.2%, the incidence of eclampsia is 41 case per 1000 live births. This review of the management of Eclampsia showed sub optimal practices. Conclusion: The incidence of eclampsia, the case fatality rate and maternal mortality due to eclampsia are unacceptably high compare to the developed societies [1, 2]. We need to improve on maternity services for antenatal care, positive pregnancy experience and early intervention.

References

Mackenzie M, Melisa RH. Eclampsia. NCBI bookshelf. A service of the national library of Medicine, National Institute of Health. Starpearls (internet), Treasure Island (FL: Starpearls publishing2024Jan.

Osama S, James J.M. Modern management of eclampsia. Postgrad med J. 1999;7575-82

Wilkerson RG, Ogunbodede AC. Hypertensive Disorders of Pregnancy. Emerg Med Clin North Am. 2019 May; 37(2):301-316. [PubMed: 30940374]

Sutton ALM, Harper LM, Titan ATN. Hypertensive Disorders in Pregnancy. Obstet Gynecol Clin North Am. 2018 Jun; 45(2):333-347. [PubMed: 29747734]

Douglas KA, Redman CWG. Eclampsia in the United Kingdom. BMJ 1994; 309:1395–400.

Bergman L, Torres-Vergara P, Penny J, Wikström J, Nelander M, Leon J, Tolcher M, Roberts JM, Wikström AK, Escudero C. Investigating Maternal Brain Alterations in Preeclampsia: The Need for a Multidisciplinary Effort. Curr Hypertens Rep. 2019 Aug 02; 21(9):72. [PubMed: 31375930]

Royal College of Obstetricians and Gynaecologists (RCOG) Guidelines No 10: Management of eclampsia. London: RCOG, 1996

GiVord RW, August PA, Chesley LC, et al. National High Blood Pressure Education Program Working Group report on high blood pressure in pregnancy. Am J Obstet Gynecol 1990; 163:1689–712

Lubbe WF. Hypertension in pregnancy; whom and how to treat. Clin Perinatol 1987; 18:845–73.

Fenakel K, Fenakel G, Appelman Z, Lurie S, Katz Z, Shoham Z. Nifedipine in the treatment of severe preeclampsia. Obstet Gynecol 1991; 77: 331–7.

Mabie WC, Gonzalez AR, Sibai BM, Amon EA. A comparative trail of labetalol and hydralazine in the acute management of severe hypertension complicating pregnancy. Obstet Gynecol 1987; 70:328–33.

Ashe RG, Moodley J, Richards AM, Philpott RH. Comparison of labetalol and dihydralazine in hypertensive emergencies of pregnancy. S Afr Med J 1987; 71:354–6.

Seabe SJ, Moodley J, Becker P. Nifedipine in acute hypertensive emergencies in pregnancy. S Afr Med J 1989; 76:248–50.

Martins-Costa S, Ramos JG, Barros E, Brano RM, Costa CA, Goldin JR. Randomized, controlled trail of hydralazine versus nifedepine in pre-eclamptic women with acute hypertension. Clin Exp Hypertens 1992; 11:25–44.

Leeman L, Dresang LT, Fontaine P. Hypertensive Disorders of Pregnancy. Am Fam Physician. 2016 Jan 15;93(2):121-7. [PubMed: 26926408]

https://www.who.int/health-topics/oxygen#tab=tab_1

Lelia Duley, David J Henderson‐Smart, Godfrey JA Walker, Doris Chou, and Cochrane Pregnancy and Childbirth Group. Magnesium sulphate versus diazepam for eclampsia. Cochrane Database Syst Rev. 2010 Dec; 2010(12): CD000127.Published online 2010 Dec 8. Doi: 10.1002/14651858.CD000127.pub2.

Hypertension in pregnancy. Report of the American College of Obstetricians and Gynecologists’ Task Force on Hypertension in Pregnancy. Obstet Gynecol. 2013 Nov; 122(5):1122-1131. [PubMed: 24150027]

Arulkumaran N, Lightstone L. Severe pre-eclampsia and hypertensive crises. Best Pract Res Clin Obstet Gynaecol. 2013 Dec; 27(6):877-84. [PubMed: 23962474]

Akogu SPO. Hypertension in Pregnancy in Akogu SPO the skilled birth Attendant, how to provide better maternal and New born care. 1st Edition Melchizedek publishers 2020 pg117.

Downloads

Published

2024-09-06

How to Cite

Akogu, S. P. O., Omoniyi, M. A., Ekpe, C., Idachaba, T., & Alakpo, F. (2024). Review of Management, Maternal and Fetal Outcomes in Women with Eclampsia in Kogi Eastern Hospitals, North Central Nigeria. British Journal of Healthcare and Medical Research, 11(5), 01–10. https://doi.org/10.14738/bjhmr.115.17521